Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 217

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery

Open access
Buniello, Annalisa, Suveges, Daniel, Cruz-Castillo, Carlos, Llinares, Manuel Bernal, Cornu, Helena, Lopez, Irene, Tsukanov, Kirill, Roldán-Romero, Juan María, Mehta, Chintan, Fumis, Luca, McNeill, Graham, Hayhurst, James D, Martinez Osorio, Ricardo Esteban, Barkhordari, Ehsan, Ferrer, Javier, Carmona, Miguel, Uniyal, Prashant, Falaguera, Maria J, Rusina, Polina, Smit, Ines, Schwartzentruber, Jeremy, Alegbe, Tobi, Ho, Vivien W, Considine, Daniel, Ge, Xiangyu, Szyszkowski, Szymon, Tsepilov, Yakov, Ghoussaini, Maya, Dunham, Ian, Hulcoop, David G, McDonagh, Ellen M, Ochoa, David · 2025 · Nucleic Acids Research

Abstract

The Open Targets Platform (https://platform.opentargets.org) is a unique, open-source, publicly-available knowledge base providing data and tooling for systematic drug target identification, annotation, and prioritisation. Since our last report, we have expanded the scope of the Platform through a number of significant enhancements and data updates, with the aim to enable our users to formulate more flexible and impactful therapeutic hypotheses. In this context, we have completely revamped our target–disease associations page with more interactive facets and built-in functionalities to empower users with additional control over their experience using the Platform, and added a new Target Prioritisation view. This enables users to prioritise targets based upon clinical precedence, tractability, doability and safety attributes. We have also implemented a direction of effect assessment for eight sources of target–disease association evidence, showing the effect of genetic variation on the function of a target is associated with risk or protection for a trait to inform on potential mechanisms of modulation suitable for disease treatment. These enhancements and the introduction of new back and front-end technologies to support them have increased the impact and usability of our resource within the drug discovery community.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/nar/gkae1128

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Metadata

Authors
Buniello, A., Suveges, D., Cruz-Castillo, C., Llinares, M. B., Cornu, H., Lopez, I., Tsukanov, K., Roldán-Romero, J. M., Mehta, C., Fumis, L., McNeill, G., Hayhurst, J. D., Martinez Osorio, R. E., Barkhordari, E., Ferrer, J., Carmona, M., Uniyal, P., Falaguera, M. J., Rusina, P., Smit, I., Schwartzentruber, J., Alegbe, T., Ho, V. W., Considine, D., Ge, X., Szyszkowski, S., Tsepilov, Y., Ghoussaini, M., Dunham, I., Hulcoop, D. G., McDonagh, E. M., & Ochoa, D.
Venue
Nucleic Acids Research
Published
2024-12-06
Volume
53
Issue
D1
Pages
D1467-D1475
ISSN
  • 0305-1048 (ISSN-L)
  • 1362-4962
OpenAlex
W4405224584
Cited by
217
References
20
FWCI
42.54
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.